Management ChangeJun 1, 2026, 04:30 PM
Seres Therapeutics Director Hans-Juergen Woerle Resigns
AI Summary
Seres Therapeutics, Inc. announced that Hans-Juergen Woerle, M.D., Ph.D. resigned from his position as a member of the board of directors, effective May 31, 2026. Dr. Woerle also resigned from the committees on which he served. The company stated that his departure was not due to any disagreement with Seres Therapeutics' operations, policies, or practices.
Key Highlights
- Hans-Juergen Woerle, M.D., Ph.D. resigned from Seres Therapeutics' board of directors.
- Dr. Woerle's resignation is effective May 31, 2026.
- His departure is not due to any disagreement with the company's operations, policies, or practices.
Price Impact
More from MCRB